MeVis Medical Solutions AG (M3V) — Net Asset Quality Index
MeVis Medical Solutions AG (M3V) has a Net Asset Quality Index of 68.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €25.89 Million minus total liabilities of €8.06 Million yields net assets of €17.83 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of MeVis Medical Solutions AG to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
MeVis Medical Solutions AG Net Asset Quality Index Over Time (2006–2025)
This chart shows how MeVis Medical Solutions AG's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of September 2025, the index stands at 68.9%, representing net assets of €17.83 Million against total assets of €25.89 Million EUR. See MeVis Medical Solutions AG (M3V) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for MeVis Medical Solutions AG (2006–2025)
The table below presents the year-by-year Net Asset Quality Index for MeVis Medical Solutions AG from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see M3V stock market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 68.9% | €17.83 Million | €25.89 Million | €8.06 Million | ▲ +1.6 pp |
| 2024 | 67.3% | €17.83 Million | €26.48 Million | €8.66 Million | ▲ +3.8 pp |
| 2023 | 63.5% | €17.83 Million | €28.05 Million | €10.23 Million | ▲ +6.4 pp |
| 2022 | 57.1% | €17.83 Million | €31.20 Million | €13.38 Million | ▼ -7.6 pp |
| 2021 | 64.7% | €17.83 Million | €27.53 Million | €9.71 Million | ▲ +0.6 pp |
| 2020 | 64.1% | €17.83 Million | €27.79 Million | €9.96 Million | ▼ -10.4 pp |
| 2019 | 74.5% | €17.83 Million | €23.92 Million | €6.09 Million | ▼ -8.9 pp |
| 2018 | 83.4% | €32.06 Million | €38.42 Million | €6.36 Million | ▲ +17.2 pp |
| 2017 | 66.2% | €32.51 Million | €49.08 Million | €16.57 Million | ▼ -10.2 pp |
| 2016 | 76.5% | €32.89 Million | €43.00 Million | €10.11 Million | ▲ +2.4 pp |
| 2015 | 74.0% | €33.73 Million | €45.55 Million | €11.82 Million | ▼ -5.1 pp |
| 2014 | 79.1% | €30.27 Million | €38.25 Million | €7.98 Million | ▲ +2.2 pp |
| 2013 | 76.9% | €26.45 Million | €34.37 Million | €7.93 Million | ▲ +3.3 pp |
| 2012 | 73.7% | €22.77 Million | €30.91 Million | €8.15 Million | ▲ +10.0 pp |
| 2011 | 63.7% | €20.73 Million | €32.55 Million | €11.82 Million | ▼ -0.2 pp |
| 2010 | 63.9% | €24.79 Million | €38.78 Million | €14.00 Million | ▼ -0.1 pp |
| 2009 | 64.0% | €32.61 Million | €50.95 Million | €18.35 Million | ▲ +9.3 pp |
| 2008 | 54.7% | €32.61 Million | €59.58 Million | €26.97 Million | ▼ -31.8 pp |
| 2007 | 86.5% | €30.77 Million | €35.58 Million | €4.81 Million | ▲ +57.3 pp |
| 2006 | 29.1% | €2.65 Million | €9.10 Million | €6.45 Million | — |